Evidence map›Paper›PMID 35206421›Full record

ArticleInternational journal of environmental research and public health2022

The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.

Rebecca S Bolinski, Suzan Walters, Elizabeth Salisbury-Afshar, Lawrence J Ouellet, Wiley D Jenkins, Ellen Almirol, Brent Van Ham, Scott Fletcher, Christian Johnson, John A Schneider and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Substance use & misuse · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Rebecca S BolinskiDepartment of Sociology, Southern Illinois University, 475 Clocktower Drive, Room 323A, Carbondale, IL 62901, USA.
Suzan WaltersCenter for Drug Use and HIV|HCV Research, School of Global Public Health, New York University, New York, NY 10003, USA.
Elizabeth Salisbury-AfsharDepartment of Family Medicine and Community Health, Madison School of Medicine and Public Health, University of Wisconsin, Madison, WI 53792, USA.ORCID 0000-0003-4096-6822
Lawrence J OuelletDivision of Epidemiology and Biostatistics/COIP (MC 923), School of Public Health, University of Illinois Chicago, 1603 W. Taylor, Chicago, IL 60607, USA.
Wiley D JenkinsEpidemiology and Biostatistics, Department of Population Science and Policy, Southern Illinois University School of Medicine, Springfield, IL 62794, USA.
Ellen AlmirolChicago Center for HIV Elimination, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9340-8635
Brent Van HamCenter for Rural Health and Social Service Development, Southern Illinois University School of Medicine, Carbondale, IL 62901, USA.
Scott FletcherThe Community Action Place, Inc., 1400 N. Wood Road Suite 7, Murphysboro, IL 62966, USA.
Christian JohnsonDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL 60637, USA.
John A SchneiderDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL 60637, USA.
Danielle OmpadCenter for Drug Use and HIV|HCV Research, School of Global Public Health, New York University, New York, NY 10003, USA.
Mai T PhoDepartment of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USNew York University · USSouthern Illinois University School of Medicine · USSouthern Illinois University Carbondale · USUniversity of Illinois Chicago · USUniversity of Wisconsin–Madison · US

Funding

BEHAVIORAL SCI TRAINING IN DRUG ABUSE RESEARCHT32DA007233 · NIDA · PUBLIC HEALTH SOLUTIONS · PI GOLDSAMT, LLOYD A · 1985 to 2023
$20.2M
Reducing Opioid Mortality in Illinois (ROMI)UG1DA050066 · NIDA · UNIVERSITY OF CHICAGO · PI PHO, MAI TUYET, POLLACK, HAROLD ALEXANDER · 2019 to 2023
$15.5M
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UH3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2019 to 2022
$5.2M
Intersectional Stigma Experiences, Pre-exposure Prophylaxis (PrEP), and Other Service Use Among People Who Inject DrugsK01DA053159 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WALTERS, SUZAN M · 2021 to 2025
$927k
NIDA NIH HHS 4UH3DA044829-03NIDA NIH HHS K01 DA053159NIDA NIH HHS K01DA053159NIDA NIH HHS P30DA01104NIDA NIH HHS T32 DA007233-31NIDA NIH HHS UG1 DA050066NIDA NIH HHS UH3 DA044829
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has worsened the opioid overdose crisis in the US. Rural communities have been disproportionately affected by opioid use and people who use drugs in these settings may be acutely vulnerable to pandemic-related disruptions due to high rates of poverty, social isolation, and pervasive resource limitations.

methodsWe performed a mixed-methods study to assess the impact of the pandemic in a convenience sample of people who use drugs in rural Illinois. We conducted 50 surveys capturing demographics, drug availability, drug use, sharing practices, and mental health symptoms. In total, 19 qualitative interviews were performed to further explore COVID-19 knowledge, impact on personal and community life, drug acquisition and use, overdose, and protective substance use adaptations.

resultsDrug use increased during the pandemic, including the use of fentanyl products such as gel encapsulated "beans" and "buttons". Disruptions in supply, including the decreased availability of heroin, increased methamphetamine costs and a concomitant rise in local methamphetamine production, and possible fentanyl contamination of methamphetamine was reported. Participants reported increased drug use alone, experience and/or witness of overdose, depression, anxiety, and loneliness. Consistent access to harm reduction services, including naloxone and fentanyl test strips, was highlighted as a source of hope and community resiliency.

conclusionsThe COVID-19 pandemic period was characterized by changing drug availability, increased overdose risk, and other drug-related harms faced by people who use drugs in rural areas. Our findings emphasize the importance of ensuring access to harm reduction services, including overdose prevention and drug checking for this vulnerable population.

Indexed as

COVID-19Drug OverdosePharmaceutical PreparationsAnalgesics, OpioidFentanylHarm ReductionHumansPandemicsRural PopulationSARS-CoV-2Analgesics, OpioidFentanylPharmaceutical PreparationsCOVID-19fentanyl beansfentanyl buttonsharm reductionmethamphetaminePWIDrural

Identifiers

PMID35206421
PMCPMC8872091
OpenAlexW4212857740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.